Nonhuman primate models of polycystic ovary syndrome

Molecular and Cellular Endocrinology

Volumn 373, Issue 1-2, 2013, Pages 21-28

  Abbott, David H ^a   Nicol, Lindsey E ^a   Levine, Jon E ^a,b   Xu, Ning ^c   Goodarzi, Mark O ^c   Dumesic, Daniel A ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen excess; Epigenome; Fetal programming; Metabolic syndrome; Monkey

Indexed keywords

ANDROSTANOLONE; DIETHYLSTILBESTROL; TESTOSTERONE;

ANIMAL MODEL; ARTICLE; DISEASE MODEL; ENDOCRINE DISEASE; EPIGENETICS; FEMALE; GENITAL SYSTEM DISEASE; GENOMICS; GESTATION PERIOD; HYPERANDROGENISM; JUVENILE ANIMAL; MENARCHE; MENSTRUATION DISORDER; METABOLIC DISORDER; NONHUMAN; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RHESUS MONKEY; WEIGHT GAIN;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INSULIN RESISTANCE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRIMATES; TESTOSTERONE;

EID: 84878115082     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.01.013     Document Type: Article

References (120)

1. Abbott A.D., Colman R.J., Tiefenthaler R., Dumesic D.A., Abbott D.H. Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys. PLoS ONE 2012, 7:e42372.
2. Abbott D.H. Differentiation of sexual behavior in female marmoset monkeys. Prog. Brain Res. 1984, 61:349-358.
3. Abbott D.H. Fibrillin 3 in the fetal ovary: can it contribute to polycystic ovary syndrome? Expert Rev. Endocrinol. Metab. 2012, 7:31-34.
4. Abbott D.H., Bird I.M. Nonhuman primates as models for human adrenal androgen production: function and dysfunction. Rev. Endocr. Metab. Disord. 2009, 10:33-42.
5. Abbott D.H., Hearn J.P. The effects of neonatal exposure to testosterone on the development of behaviour in female marmoset monkeys. Ciba Found Symp. 1978, 62:299-327.
6. Abbott D.H., Dumesic D.A., Eisner J.R., Colman R.J., Kemnitz J.W. Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol. Metab. 1998, 9:62-67.
7. Abbott D.H., Dumesic D.A., Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J. Endocrinol. 2002, 174:1-5.
8. Abbott D.H., Barnett D.K., Bruns C.M., Dumesic D.A. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?. Hum. Reprod. Update 2005, 11:357-374.
9. Abbott D.H., Barnett D.K., Levine J.E., Padmanabhan V., Dumesic D.A., Jacoris S., Tarantal A.F. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol. Reprod. 2008, 79:154-163.
10. Abbott, D.H., Roy, S.K., Manikkam, M., Tarantal, A.F., Dumesic, D.A., Padmanabhan, V., 2008b. Diminished ovarian follicle recruitment with reduced androgen receptor expression in female infant rhesus monkeys exposed to androgen excess during early gestation. [Abstract] Endocrine Society - Annual Meeting Abstracts. 90. Pgs: Abst # Or30-5.
11. Abbott D.H., Tarantal A.F., Dumesic D.A. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am. J. Primatol. 2009, 71:776-784.
12. Abbott D.H., Bruns C.R., Barnett D.K., Dunaif A., Goodfriend T.L., Dumesic D.A., Tarantal A.F. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E741-E751.
13. Anderson H., Fogel N., Grebe S.K., Singh R.J., Taylor R.L., Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J. Clin. Endocrinol. Metab. 2010, 95:2180-2186.
14. Arifin E., Shively C.A., Register T.C., Cline J.M. Polycystic ovary syndrome with endometrial hyperplasia in a cynomolgus monkey (Macaca fascicularis). Vet. Pathol. 2008, 45:512-515.
15. Auger C.J., Coss D., Auger A.P., Forbes-Lorman R.M. Epigenetic control of vasopressin expression is maintained by steroid hormones in the adult male rat brain. Proc. Natl. Acad. Sci. USA 2011, 108:4242-4247.
16. Barry J.A., Kay A.R., Navaratnarajah R., Iqbal S., Bamfo J.E., David A.L., Hines M., Hardiman P.J. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J. Obstet. Gynaecol. 2010, 30:444-446.
17. Beck-Peccoz P., Padmanabhan V., Baggiani A.M., Cortelazzi D., Buscaglia M., Medri G., Marconi A.M., Pardi G., Beitins I.Z. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 1991, 73:525-532.
18. Billiar R.B., Richardson D., Anderson E., Mahajan D., Little B. The effect of chronic and acyclic elevation of circulating androstenedione or estrone concentrations on ovarian function in the rhesus monkey. Endocrinology 1985, 116:2209-2220.
19. Billiar R.B., Richardson D., Schwartz R., Posner B., Little B. Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. Am. J. Obstet. Gynecol. 1987, 157:1297-1302.
20. Blank S.K., McCartney C.R., Marshall J.C. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum. Reprod. Update 2006, 12:351-361.
21. Blank S.K., McCartney C.R., Helm K.D., Marshall J.C. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin. Reprod. Med. 2007, 25:352-359.
22. Blank S.K., McCartney C.R., Chhabra S., Helm K.D., Eagleson C.A., Chang R.J., Marshall J.C. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls-implications for regulation of pubertal maturation. J. Clin. Endocrinol. Metab. 2009, 94:2360-2366.
23. Chhabra S., et al. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J. Clin. Endocrinol. Metab. 2005, 90:2810-2815.
24. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
25. Conley A.J., Moeller B.C., Nguyen A.D., Stanley S.D., Plant T.M., Abbott D.H. Defining adrenarche in the rhesus macaque (Macaca mulatta), a non-human primate model for adrenal androgen secretion. Mol. Cell. Endocrinol. 2011, 336:110-116.
26. Conley A.J., Bernstein R.M., Nguyen A.D. Adrenarche in Non-human Primates: the evidence for it and the need to re-define it. J. Endocrinol. 2012, 214:121-131.
27. Coviello A.D., Legro R.S., Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 2006, 91:492-497.
28. Crisosto N., Echiburú B., Maliqueo M., Pérez V., Ladrón de Guevara A., Preisler J., Sánchez F., Sir-Petermann T. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. Fertil. Steril. 2012, 97:218-224.
29. Dawson P.A. Sulfate in fetal development. Semin. Cell Dev. Biol. 2011, 22:653-659.
30. Dietz W.H. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998, 101:518-525.
31. Dubey A.K., Herbert J., Abbott D.H., Martensz N.D. Serum and CSF concentrations of testosterone and LH related to negative feedback in male rhesus monkeys. Neuroendocrinology 1984, 39:176-185.
32. Dumesic D.A., Abbott D.H., Eisner J.R., Goy R.W. Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil. Steril. 1997, 67:155-163.
33. Dumesic D.A., Schramm R.D., Peterson E., Paprocki A.M., Zhou R., Abbott D.H. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J. Clin. Endocrinol. Metab. 2002, 87:1111-1119.
34. Dumesic D.A., Schramm R.D., Bird I.M., Peterson E., Paprocki A.M., Zhou R., Abbott D.H. Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization. Biol. Reprod. 2003, 69:1213-1219.
35. Dumesic D.A., Schramm R.D., Abbott D.H. Early origins of polycystic ovary syndrome. Reprod. Fertil. Dev. 2005, 17:349-360.
36. Dumesic D.A., Patankar M.S., Barnett D.K., Lesnick T.G., Hutcherson B.A., Abbott D.H. Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys. Hum. Reprod. 2009, 24:3188-3195.
37. Ehrmann D.A., et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006, 91:48-53.
38. Eisner J.R., Barnett M.A., Dumesic D.A., Abbott D.H. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil. Steril. 2002, 77:167-172.
39. Ewens K.G., et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2010, 95:2306-2315.
40. Faiman C., Reyes F.I., Dent D.W., Fuller G.B., Hobson W.C., Thliveris J.A. Effects of long-term testosterone exposure on ovarian function and morphology in the rhesus monkey. Anat. Rec. 1988, 222:245-251.
41. Fauser B.C., Tarlatzis B.C., Rebar R.W., Legro R.S., Balen A.H., Lobo R., Carmina E., Chang J., Yildiz B.O., Laven J.S., Boivin J., Petraglia F., Wijeyeratne C.N., Norman R.J., Dunaif A., Franks S., Wild R.A., Dumesic D., Barnhart K. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil. Steril. 2012, 97(28-38):e25.
42. Franks S. Adult polycystic ovary syndrome begins in childhood. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16:263-272.
43. Franks S., Stark J., Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum. Reprod. Update 2008, 14:367-378.
44. Foecking E.M., Szabo M., Schwartz N.B., Levine J.E. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biol. Reprod. 2005, 72:1475-1483.
45. Fuller G.B., Yates D.E., Helton E.D., Hobson W.C. Diethylstilbestrol reversal of gonadotropin patterns in infant rhesus monkeys. J. Steroid. Biochem. 1981, 15:497-500.
46. Gaikwad A.B., Gupta J., Tikoo K. Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem. J. 2010, 432:333-341.
47. Gibbs R.A., et al. Rhesus macaque genome sequencing and analysis consortium, evolutionary and biomedical insights from the rhesus macaque genome. Science 2007, 316:222-234.
48. Gilling-Smith C., Story H., Rogers V., Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. (Oxford) 1997, 47:93-99.
49. Goodarzi M.O. Looking for polycystic ovary syndrome genes: rational and best strategy. Semin. Reprod. Med. 2008, 26:5-13.
50. Goy R.W., Robinson J.A. Prenatal exposure of rhesus monkeys to patent androgens: morphological, behavioral, and physiological consequences. Banbury Report II: Environmental Factors in Human Growth and Development 1982, 355-378. Cold Spring Harbor Laboratory, Cold Spring Harbor. V.R. Hunt, M.K. Smith, D. Worth (Eds.).
51. Goy R.W., Uno H., Sholl S.A. Physiological and anatomical consequences of prenatal exposure to androgens in female rhesus. Toxicity of Hormones in Perinatal Life 1988, 127-142. CRC Press Inc., Boca Raton. T. Mori, H. Nagasawa (Eds.).
52. Hart R., Doherty D.A., Norman R.J., Franks S., Dickinson J.E., Hickey M., Sloboda D.M. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil. Steril. 2010, 94:1118-1121.
53. Hatzirodos N., Bayne R.A., Irving-Rodgers H.F., Hummitzsch K., Sabatier L., Lee S., Bonner W., Gibson M.A., Rainey W.E., Carr B.R., Mason H.D., Reinhardt D.P., Anderson R.A., Rodgers R.J. Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome. FASEB J. 2011, 25:2256-2265.
54. Hedley A.A., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
55. Heijnen E.M.E.W., Eijkemans M.J.C., Hughes E.G., Laven J.S.E., Macklon N.S., Fauser B.C.J.M. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum. Reprod. Update 2006, 12:13-21.
56. Hendrickx A.G., Prahalada S., Binkerd P.E. Long-term evaluation of the diethylstilbestrol (DES) syndrome in adult female rhesus monkeys (Macaca mulatta). Reprod. Toxicol. 1987-1988, 1:253-261.
57. Hickey M., Sloboda D.M., Atkinson H.C., Doherty D.A., Franks S., Norman R.J., Newnham J.P., Hart R. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence. a prospective cohort study. J. Clin. Endocrinol. Metab. 2009, 94:3714-3720.
58. Hogg K., McNeilly A.S., Duncan W.C. Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology 2011, 152:2048-2059.
59. Hogg K., Young J.M., Oliver E.M., Souza C.J., McNeilly A.S., Duncan W.C. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology 2012, 153:450-461.
60. Ibanez L., et al. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin. Endocrinol. (Oxford) 2003, 58:372-379.
61. Idkowiak J., Lavery G.G., Dhir V., Barrett T.G., Stewart P.M., Krone N., Arlt W. Premature adrenarche: novel lessons from early onset androgen excess. Eur. J. Endocrinol. 2011, 165:189-207.
62. Jones M.R., Wilson S.G., Mullin B.H., Mead R., Watts G.F., et al. Polymorphism of the follistatin gene in polycystic ovary syndrome. Mol. Hum. Reprod. 2007, 13:237-241.
63. Kaplan J.R., Chen H., Appt S.E., Lees C.J., Franke A.A., Berga S.L., Wilson M.E., Manuck S.B., Clarkson T.B. Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet. Hum. Reprod. 2010, 25:3083-3094.
64. Kiddy D.S., et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. (Oxford) 1990, 32:213-220.
65. Legro R.S., Driscoll D., Strauss J.F., Fox J., Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA 1998, 95:14956-14960.
66. Levine, J.E., Terasawa, E., Hoffman, S.M., Dobbert, M.J.W., Foecking, E.M., Abbott, D.H., 2005. Luteinizing hormone (LH) hypersecretion and diminished LH responses to RU486 in a nonhuman primate model for polycystic ovary syndrome (PCOS). Abstract P1-85 presented at the 87th Annual Meeting of the Endocrine Society, San Diego, CA, p. 188.
67. Lujan M.E., Bloski T.G., Chizen D.R., Lehotay D.C., Pierson R.A. Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. Hum. Reprod. 2010, 25:204-211.
68. Lujan M.E., Podolski A.J., Chizen D.R., Lehotay D.C., Pierson R.A. Digit ratios by computer-assisted analysis confirm lack of anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. Reprod. Biol. Endocrinol. 2010, 8:156.
69. Manikkam M., Crespi E.J., Doop D.D., Herkimer C., Lee J.S., Yu S., Brown M.B., Foster D.L., Padmanabhan V. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004, 145:790-798.
70. Marshall J.C. Obesity in adolescent girls: is excess androgen the real bad actor?. J. Clin. Endocrinol. Metab. 2006, 91:393-395.
71. McCartney C.R., et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J. Clin. Endocrinol. Metab. 2006, 91:1714-1722.
72. McCartney C.R., et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J. Clin. Endocrinol. Metab. 2007, 92:430-436.
73. McCartney C.R. Maturation of sleep-wake gonadotrophin-releasing hormone secretion across puberty in girls: potential mechanisms and relevance to the pathogenesis of polycystic ovary syndrome. J. Neuroendocrinol. 2010, 22:701-709.
74. McGee W.K., Bishop C.V., Bahar A., Pohl C.R., Chang R.J., Marshall J.C., Pau F.K., Stouffer R.L., Cameron J.L. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Hum. Reprod. 2012, 27:531-540.
75. McIntyre M.H. The use of digit ratios as markers for perinatal androgen action. Reprod. Biol. Endocrinol. 2006, 4:10.
76. Moran L., Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum. Reprod. Update 2009, 15:477-488.
77. Nelson V.L., Legro R.S., Strauss J.F., McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 1999, 13:946-957.
78. Nicol L.E., O'Brien T.D., Parker J., Dumesic D.A., Abbott D.H. Adult and infant islet morphology in a monkey model with diminished glucoregulation. Horm. Res. 2009, 72(Suppl. 3):329.
79. Padmanabhan V., Veiga-Lopez A. Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin. Reprod. Med. 2011, 29:173-186.
80. Pellatt L., Rice S., Mason H.D. Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?. Reproduction 2010, 139:825-833.
81. Pirola L., Balcerczyk A., Okabe J., El-Osta A. Epigenetic phenomena linked to diabetic complications. Nat. Rev. Endocrinol. 2010, 6:665-675.
82. Pirola L., Balcerczyk A., Tothill R.W., Haviv I., Kaspi A., Lunke S., Ziemann M., Karagiannis T., Tonna S., Kowalczyk A., Beresford-Smith B., Macintyre G., Kelong M., Hongyu Z., Zhu J., El-Osta A. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 2011, 21:1601-1615.
83. Raja-Khan N., Kunselman A.R., Demers L.M., Ewens K.G., Spielman R.S., et al. A variant in the fibrillin-3 gene is associated with TGF-beta and inhibin B levels in women with polycystic ovary syndrome. Fertil. Steril. 2010, 94:2916-2919.
84. Resko J.A., Buhl A.E., Phoenix C.H. Treatment of pregnant rhesus macaques with testosterone propionate: observations on its fate in the fetus. Biol. Reprod. 1987, 37:1185-1191.
85. Roe A.H., Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev. Obstet. Gynecol. 2011, 4:45-51.
86. Robinson J.E., Grindrod J., Jeurissen S., Taylor J.A., Unsworth W.P. Prenatal exposure of the ovine fetus to androgens reduces the proportion of neurons in the ventromedial and arcuate nucleus that are activated by short-term exposure to estrogen. Biol. Reprod. 2010, 82:163-170.
87. Rosenfield R.L. Clinical review: identifying children at risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007, 92:787-796.
88. Sarma H.N., Manikkam M., Herkimer C., Dell'Orco J., Welch K.B., Foster D.L., Padmanabhan V. Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology 2005, 146:4281-4291.
89. Shayya R., Chang R.J. Reproductive endocrinology of adolescent polycystic ovary syndrome. BJOG 2010, 117:150-155.
90. Slob A.K., den Hamer R., Woutersen P.J., van der Werff ten Bosch J.J. Prenatal testosterone propionate and postnatal ovarian activity in the rat. Acta Endocrinol. (Copenh) 1983, 103:420-427.
91. Siow Y., Kives S., Hertweck P., Perlman S., Fallat M.E. Serum Müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome. Fertil. Steril. 2005, 84:938-944.
92. Sir-Petermann T., Codner E., Maliqueo M., Echiburú B., Hitschfeld C., Crisosto N., Pérez-Bravo F., Recabarren S.E., Cassorla F. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006, 91:3105-3109.
93. Sir-Petermann T., Codner E., Pérez V., Echiburú B., Maliqueo M., Ladrón de Guevara A., Preisler J., Crisosto N., Sánchez F., Cassorla F., Bhasin S. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2009, 94:1923-1930.
94. Sir-Petermann T., Guevara A.L., Codner E., Preisler J., Crisosto N., Echiburú B., Maliqueo M., Sánchez F., Perez-Bravo F., Cassorla F. Relationship between Anti-Mullerian Hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome. Reprod. Sci. 2012, 19:383-390.
95. Steiner R.A., Clifton D.K., Spies H.G., Resko J.A. Sexual differentiation and feedback control of luteinizing hormone secretion in the rhesus monkey. Biol. Reprod. 1976, 15:206-212.
96. Terasawa E., Kurian J.R., Keen K.L., Shiel N.A., Colman R.J., Capuano S.V. Body weight impact on puberty: effects of high-calorie diet on puberty onset in female rhesus monkeys. Endocrinology 2012, 153:1696-1705.
97. Treloar O.L., Wolf R.C., Meyer R.K. Failure of a single neonatal dose of testosterone to alter ovarian function in the rhesus monkey. Endocrinology 1972, 90:281-284.
98. Trounson A., Grieshammer U. Chimeric primates: embryonic stem cells need not apply. Cell 2012, 148:19-21.
99. Urbanek M., Sam S., Legro R.S., Dunaif A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J. Clin. Endocrinol. Metab. 2007, 92:4191-4198.
100. Ugele B., St-Pierre M.V., Pihusch M., Bahn A., Hantschmann P. Characterization and identification of steroid sulfate transporters of human placenta. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E390-E398.
101. Ugele B., Bahn A., Rex-Haffner M. Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta. J. Steroid Biochem. Mol. Biol. 2008, 111:1-6.
102. Urbanek M., Legro R.S., Driscoll D.A., Azziz R., Ehrmann D.A., et al. Thirtyseven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. USA 1999, 96:8573-8578.
103. Van Wagenen G. Accelerated growth with sexual precocity in female monkeys receiving testosterone propionate. Endocrinology 1949, 45:544-546.
104. Vendola K.A., Zhou J., Adesanya O.O., Weil S.J., Bondy C.A. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest. 1998, 101:2622-2629.
105. Vendola K., Zhou J., Wang J., et al. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum. Reprod. 1999, 14:2328-2332.
106. Vendola K., Zhou J., Wang J., Bondy C.A. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum. Reprod. 1999, 14:2328-2332.
107. Vink J.M., Sadrzadeh S., Lambalk C.B., Boomsma D.I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 2006, 91:2100-2104.
108. Walters K.A., Allan C.M., Handelsman D.J. Rodent models for human polycystic ovary syndrome. Biol. Reprod. 2012, 86:149.
109. Weil S., Vendola K., Zhou J., et al. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J. Clin. Endocrinol. Metab. 1999, 84:2951-2956.
110. Wild R.A., Carmina E., Diamanti-Kandarakis E., Dokras A., Escobar-Morreale H.F., Futterweit W., Lobo R., Norman R.J., Talbott E., Dumesic D.A. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 2010, 95:2038-2049.
111. Wood J.R., Dumesic D.A., Abbott D.H., Strauss J.F. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J. Clin. Endocrinol. Metab. 2007, 92:705-713.
112. Xu N., Kwon S., Abbott D.H., Geller D.H., Dumesic D.A., Azziz R., Guo X., Goodarzi M.O. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS ONE 2011, 6:e27286.
113. Yalamanchi S.K., Sam S., Cardenas M.O., Holaday L.W., Urbanek M., Dunaif A. Association of Fibrillin-3 and Transcription Factor-7-Like 2 Gene Variants With Metabolic Phenotypes in PCOS. Obesity (Silver Spring) 2012, 20:1273-1278.
114. Zeleznik A.J., Little-Ihrig L., Ramasawamy S. Administration of insulin-like growth factor I to rhesus monkeys does not augment gonadotropin-stimulated ovarian steroidogenesis. J. Clin. Endocrinol. Metab. 2002, 87:5722-5729.
115. Zeleznik A.J., Little-Ihrig L., Ramasawamy S. Administration of dihydrotestosterone to rhesus monkeys inhibits gonadotropin-stimulated ovarian steroidogenesis. J. Clin. Endocrinol. Metab. 2004, 89:860-866.
116. Zhang X., Zhang R., Raab S., Zheng W., Wang J., Liu N., Zhu T., Xue L., Song Z., Mao J., Li K., Zhang H., Zhang Y., Han C., Ding Y., Wang H., Hou N., Liu Y., Shang S., Li C., Sebokova E., Cheng H., Huang P.L. Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone. Circulation 2011, 124:77-86.
117. Zhou R., Bird I.M., Dumesic D.A., Abbott D.H. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2005, 90:6630-6637.
118. Zhou R., Bruns C.M., Bird I.M., Kemnitz J.W., Goodfriend T.L., Dumesic D.A., Abbott D.H. Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod. Toxicol. 2007, 23:438-448.
119. Zhou, R., Bruns, C.M., Bird, I.M., Kemnitz, J.W., Dumesic, D.A., Abbott, D.H., 2007b. Chronic insulin therapy fails to disrupt ovulation in a nonhuman primate model for polycystic ovary syndrome (PCOS). Abstract P2-349 presented at the 89th Annual Meeting of the Endocrine Society, Toronto, Canada.
120. Zumoff B., et al. A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N. Engl. J. Med. 1983, 309:1206-1209.